Tvardi Therapeutics, Inc.

Tvardi Therapeutics (TVRD) Options Chain & Prices 2026 $TVRD
MarketBeat · 23 Oct 2026
Tvardi at Chardan healthcare conference: new data lifts stat3 hopes
Investing.com · 20 Oct 2026
Why is Tvardi Therapeutics stock climbing 5% today? By Investing.com
Investing.com India · 20 Oct 2026
Chardan initiates Tvardi Therapeutics stock with buy on STAT3 platform
Investing.com · 20 Oct 2026
Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference
GlobeNewswire · 14 Oct 2026
New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)
GlobeNewswire · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.